US · Healthcare

MiMedx Group Inc (MDXG)

Biotechnology

MiMedx Group Inc (MDXG) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MDXG

P/E ratio

18.00

MiMedx Group Inc (MDXG) — FAQ

What is MDXG's P/E ratio?

The price-to-earnings (P/E) ratio for MiMedx Group Inc (MDXG) is 18.00 (data as of 2026-03-24).

Does MiMedx Group Inc pay a dividend?

Dividend yield is not available in the current snapshot for MiMedx Group Inc (MDXG). Check the MyAverix Finance app for the latest dividend data.

What sector is MiMedx Group Inc in?

MiMedx Group Inc (MDXG) is classified in the Healthcare sector (Biotechnology industry).

What exchange is MDXG listed on?

MDXG is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)